Fresenius continues steady growth:
This article was originally published in Clinica
Executive Summary
First-quarter turnover at Fresenius rose 13% to DM 534 million ($368 million), almost entirely due to foreign business. Revenue breakdown by division was: dialysis technology 56%; pharmaceuticals 33%; critical care and diagnostics 7%; and project business 4%. Net income was DM 15 million, up 19% compared with 1994. Fresenius expects total sales in 1995 to rise 10%.